Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 11, 1999, Pages 2471-2480

  Mäkitie, Teemu ^a   Summanen, Paula ^a   Tarkkanen, Ahti ^a   Kivelä, Tero ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURVIVAL; CELL TYPE; CHOROID MELANOMA; ENUCLEATION; FEMALE; HUMAN; MALE; MICROVASCULARIZATION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR CELL; TUMOR VASCULARIZATION; TUMOR VOLUME; UVEA MELANOMA;

ACTINS; ANTIGENS, CD34; CHOROID NEOPLASMS; CILIARY BODY; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MELANOMA; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES; UVEAL NEOPLASMS; VON WILLEBRAND FACTOR;

EID: 0344631585     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147:9-19.
2. de Jong JS, van Diest PJ, Baak JPA. Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest. 1995;73: 922-926.
3. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new, significant, and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 1992;84:1875-1887.
4. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
5. Van Hoef MEHM, Knox WF, Dhesi SS, Howell A, Schor AM. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer. 1993;29A: 1141-1145.
6. Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol. 1998;184:119-122.
7. Foss AJE, Alexander RA, Hungerford JL, et al. Reassessment of the PAS patterns in uveal melanoma. Br J Ophthalmol. 1997;81:240-246.
8. Foss AJE, Alexander RA, Jefferies LW, et al. Microvessel count predicts survival in uveal melanoma. Cancer Res. 1996;56:2900-2903.
9. Schaling DF, Van der Pol JP, Schlingemann RO, Parys-van Ginderdeuren R, et al. Vascular density and vascular patterns in the prognosis of choroidal melanoma. In: Schaling DF, ed. Radionuclides and Radiolabelled Antibodies in Choroidal melanoma (diagnosis and therapy). Leiden: Rijksuniversiteit te Leiden; 1996;43-54.
10. Lane AM, Egan KM, Yang J, et al. An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma. Melanoma Res. 1997;7:237-242.
11. Miller MV, Herdson PB, Hitchcock GC. Malignant melanoma of the uveal tract: a review of the Auckland experience. Pathology. 1985;17:281-284.
12. Folberg R, Rummelt V, Parys-van Ginderdeuren R, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 1993;100:1389-1398.
13. Mehaffey MG, Folberg R, Meyer M, et al. Relative importance of quantifying area and vascular patterns in uveal melanomas. Am J Ophthalmol. 1997;123:798-809.
14. Rummelt V, Folberg R, Woolson RF, Hwang T, Pe'er J. Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas. Ophthalmology. 1995;102:844-851.
15. Seregard S, Spangberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology. 1998;105:485-491.
16. McLean IW, Keefe KS, Burnier MN. Uveal melanoma: comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology. 1997; 104:777-780.
17. Pe'er J, Rummelt V, Mawn L, et al. Mean of the ten largest nucleoli, microcirculation architecture, and prognosis of ciliochoroidal melanomas. Ophthalmology. 1994;101:1227-1235.
18. Rummelt V, Folberg R, Rummelt C, et al. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid: a comparative histopathologic and ultra-structural study. Ophthalmology. 1994;101:718-727.
19. Folberg R, Pe'er J, Gruman LM, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol. 1992;23:1298-1305.
20. Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst. 1999;91:359-367.
21. McLean IW, Foster WD, Zimmerman LE. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol. 1982;13:123-132.
22. Sakamoto T, Sakamoto M, Yoshikawa H, et al. Histologic findings and prognosis of uveal malignant melanoma in Japanese patients. Am J Ophthalmol. 1996;121:276-283.
23. Folberg R, Mehaffey M, Gardner LM, et al. The microcirculation of choroidal and ciliary body melanomas. Eye. 1997;11:227-238.
24. Borenstein M. Planning for precision in survival studies. J Clin Epidemiol. 1994;47:1277-1285.
25. Parmar MKB, Machin D. Survival Analysis: A Practical Approach. Chichester, UK: John Wiley & Sons; 1996.
26. Fuchs U, Kivelä T, Summanen P, Immonen I, Tarkkanen A. An immunohistochemical and prognostic analysis of cylokeratin expression in malignant uveal melanoma. Am J Pathol. 1992;141: 169-181.
27. Ramani P, Bradley NJ, Fletcher CDM. QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections. Histopathology. 1990;17:237-242.
28. Anthony PP, Ramani P. Endothelial markers in malignant vascular tumours of the liver: superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin 1. J Clin Pathol. 1991;44:29-32.
29. Skalli O, Ropraz P, Trzeciak A, et al. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986;103:2787-2796.
30. Kivelä T. Immunohistochemical staining followed by bleaching of melanin: a practical method for ophthalmic pathology. Br J Biomed Sci. 1995;52:325-326.
31. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall; 1991.
32. Lee AHS, Altman DG. Correspondence. Lab Invest. 1996;75:755-756.
33. Kleinbaum DG. Survival Analysis: A Self-Learning Text. New York: Springer-Verlag; 1996.
34. Grossniklaus HE. Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma. Trans Am Ophthalmol Soc. 1998;96:721-752.
35. Fox SB, Leek RD, Weekes MP, et al. Quantification and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol. 1995;177:275-283.
36. Folberg R. Discussion of paper by Foss et al. Br J Ophthalmol. 1997;81:247-248.